{"transactions":[{"id":729581,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-23T23:55:15.000Z","date":"2026-06-20","kind":"exercise","planned":false,"acquired":false,"shares":18880,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 20, 2025 grant date subject to continued service on the Company's Board of Directors through the vesting date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 20, 2025 grant date subject to continued service on the Company's Board of Directors through the vesting date"}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":18880},"source":{"system":"sec-edgar","filing":"0001104659-26-076926","document":"tm2618639-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926076926/tm2618639-5_4seq1.xml","form_type":"4"}},{"id":729580,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-23T23:55:15.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":14180,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, will vest on the first anniversary of the June 18, 2026 grant date subject to continued service on the Company's Board of Directors through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, will vest on the first anniversary of the June 18, 2026 grant date subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":14180,"derivative":{"underlying":"Common Stock","underlying_shares":14180},"source":{"system":"sec-edgar","filing":"0001104659-26-076926","document":"tm2618639-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926076926/tm2618639-5_4seq1.xml","form_type":"4"}},{"id":729579,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-23T23:55:15.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":21270,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One hundred percent (100%) of the shares subject to this option grant under the Amended and Restated 2015 Stock Incentive Plan, as amended, will vest on the first anniversary of the June 18, 2026 grant date subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":21270,"derivative":{"exercise_price":9.13,"expiration_date":"2036-06-18","underlying":"Common Stock","underlying_shares":21270},"source":{"system":"sec-edgar","filing":"0001104659-26-076926","document":"tm2618639-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926076926/tm2618639-5_4seq1.xml","form_type":"4"}},{"id":729578,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-23T23:55:15.000Z","date":"2026-06-20","kind":"exercise","planned":false,"acquired":true,"shares":18880,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."}],"balance_after":44468,"source":{"system":"sec-edgar","filing":"0001104659-26-076926","document":"tm2618639-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926076926/tm2618639-5_4seq1.xml","form_type":"4"}},{"id":800285,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2026-04-27T20:42:58.000Z","date":"2026-04-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":74872,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"In connection with consummation of the Merger, each reported stock option (\"Option\") was cancelled and converted into the right to receive a cash payment equal to (a) the excess of (i) $14.50 per share over (ii) the exercise price payable per share, multiplied by (b) the total number of shares subject to such Option."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In connection with consummation of the Merger, each reported stock option (\"Option\") was cancelled and converted into the right to receive a cash payment equal to (a) the excess of (i) $14.50 per share over (ii) the exercise price payable per share, multiplied by (b) the total number of shares subject to such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each Option vested in full in connection with consummation of the Merger."}],"balance_after":0,"derivative":{"exercise_price":5.96,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":74872},"source":{"system":"sec-edgar","filing":"0001193125-26-182284","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000119312526182284/ownership.xml","form_type":"4"}},{"id":800284,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2026-04-27T20:42:58.000Z","date":"2026-04-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":42467,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"In connection with consummation of the Merger, each reported stock option (\"Option\") was cancelled and converted into the right to receive a cash payment equal to (a) the excess of (i) $14.50 per share over (ii) the exercise price payable per share, multiplied by (b) the total number of shares subject to such Option."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In connection with consummation of the Merger, each reported stock option (\"Option\") was cancelled and converted into the right to receive a cash payment equal to (a) the excess of (i) $14.50 per share over (ii) the exercise price payable per share, multiplied by (b) the total number of shares subject to such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each Option was fully vested."}],"balance_after":0,"derivative":{"exercise_price":10.27,"expiration_date":"2034-06-06","underlying":"Common Stock","underlying_shares":42467},"source":{"system":"sec-edgar","filing":"0001193125-26-182284","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000119312526182284/ownership.xml","form_type":"4"}},{"id":800283,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2026-04-27T20:42:58.000Z","date":"2026-04-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":30474,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"In connection with consummation of the Merger, each reported stock option (\"Option\") was cancelled and converted into the right to receive a cash payment equal to (a) the excess of (i) $14.50 per share over (ii) the exercise price payable per share, multiplied by (b) the total number of shares subject to such Option."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In connection with consummation of the Merger, each reported stock option (\"Option\") was cancelled and converted into the right to receive a cash payment equal to (a) the excess of (i) $14.50 per share over (ii) the exercise price payable per share, multiplied by (b) the total number of shares subject to such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each Option was fully vested."}],"balance_after":0,"derivative":{"exercise_price":12.62,"expiration_date":"2033-06-08","underlying":"Common Stock","underlying_shares":30474},"source":{"system":"sec-edgar","filing":"0001193125-26-182284","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000119312526182284/ownership.xml","form_type":"4"}},{"id":800282,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2026-04-27T20:42:58.000Z","date":"2026-04-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":45423,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"In connection with consummation of the Merger, each reported stock option (\"Option\") was cancelled and converted into the right to receive a cash payment equal to (a) the excess of (i) $14.50 per share over (ii) the exercise price payable per share, multiplied by (b) the total number of shares subject to such Option."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In connection with consummation of the Merger, each reported stock option (\"Option\") was cancelled and converted into the right to receive a cash payment equal to (a) the excess of (i) $14.50 per share over (ii) the exercise price payable per share, multiplied by (b) the total number of shares subject to such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each Option was fully vested."}],"balance_after":0,"derivative":{"exercise_price":8.55,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":45423},"source":{"system":"sec-edgar","filing":"0001193125-26-182284","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000119312526182284/ownership.xml","form_type":"4"}},{"id":800281,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2026-04-27T20:42:58.000Z","date":"2026-04-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":36111,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"In connection with consummation of the Merger, each reported stock option (\"Option\") was cancelled and converted into the right to receive a cash payment equal to (a) the excess of (i) $14.50 per share over (ii) the exercise price payable per share, multiplied by (b) the total number of shares subject to such Option."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In connection with consummation of the Merger, each reported stock option (\"Option\") was cancelled and converted into the right to receive a cash payment equal to (a) the excess of (i) $14.50 per share over (ii) the exercise price payable per share, multiplied by (b) the total number of shares subject to such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each Option was fully vested."}],"balance_after":0,"derivative":{"exercise_price":10.71,"expiration_date":"2031-06-10","underlying":"Common Stock","underlying_shares":36111},"source":{"system":"sec-edgar","filing":"0001193125-26-182284","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000119312526182284/ownership.xml","form_type":"4"}},{"id":800280,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2026-04-27T20:42:58.000Z","date":"2026-04-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":18574,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"In connection with consummation of the Merger, each reported stock option (\"Option\") was cancelled and converted into the right to receive a cash payment equal to (a) the excess of (i) $14.50 per share over (ii) the exercise price payable per share, multiplied by (b) the total number of shares subject to such Option."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In connection with consummation of the Merger, each reported stock option (\"Option\") was cancelled and converted into the right to receive a cash payment equal to (a) the excess of (i) $14.50 per share over (ii) the exercise price payable per share, multiplied by (b) the total number of shares subject to such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each Option was fully vested."}],"balance_after":0,"derivative":{"exercise_price":12.81,"expiration_date":"2030-06-04","underlying":"Common Stock","underlying_shares":18574},"source":{"system":"sec-edgar","filing":"0001193125-26-182284","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000119312526182284/ownership.xml","form_type":"4"}},{"id":800279,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2026-04-27T20:42:58.000Z","date":"2026-04-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":19473,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"In connection with consummation of the Merger, each reported stock option (\"Option\") was cancelled and converted into the right to receive a cash payment equal to (a) the excess of (i) $14.50 per share over (ii) the exercise price payable per share, multiplied by (b) the total number of shares subject to such Option."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In connection with consummation of the Merger, each reported stock option (\"Option\") was cancelled and converted into the right to receive a cash payment equal to (a) the excess of (i) $14.50 per share over (ii) the exercise price payable per share, multiplied by (b) the total number of shares subject to such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each Option was fully vested."}],"balance_after":0,"derivative":{"exercise_price":12,"expiration_date":"2029-06-27","underlying":"Common Stock","underlying_shares":19473},"source":{"system":"sec-edgar","filing":"0001193125-26-182284","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000119312526182284/ownership.xml","form_type":"4"}},{"id":800278,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2026-04-27T20:42:58.000Z","date":"2026-04-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":16236,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"In connection with consummation of the Merger, each reported stock option (\"Option\") was cancelled and converted into the right to receive a cash payment equal to (a) the excess of (i) $14.50 per share over (ii) the exercise price payable per share, multiplied by (b) the total number of shares subject to such Option."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In connection with consummation of the Merger, each reported stock option (\"Option\") was cancelled and converted into the right to receive a cash payment equal to (a) the excess of (i) $14.50 per share over (ii) the exercise price payable per share, multiplied by (b) the total number of shares subject to such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each Option was fully vested."}],"balance_after":0,"derivative":{"exercise_price":8.6,"expiration_date":"2027-06-13","underlying":"Common Stock","underlying_shares":16236},"source":{"system":"sec-edgar","filing":"0001193125-26-182284","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000119312526182284/ownership.xml","form_type":"4"}},{"id":800277,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2026-04-27T20:42:58.000Z","date":"2026-04-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"In connection with consummation of the Merger, each reported stock option (\"Option\") was cancelled and converted into the right to receive a cash payment equal to (a) the excess of (i) $14.50 per share over (ii) the exercise price payable per share, multiplied by (b) the total number of shares subject to such Option."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In connection with consummation of the Merger, each reported stock option (\"Option\") was cancelled and converted into the right to receive a cash payment equal to (a) the excess of (i) $14.50 per share over (ii) the exercise price payable per share, multiplied by (b) the total number of shares subject to such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each Option was fully vested."}],"balance_after":0,"derivative":{"exercise_price":6.71,"expiration_date":"2026-06-09","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001193125-26-182284","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000119312526182284/ownership.xml","form_type":"4"}},{"id":800276,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-27T20:42:58.000Z","date":"2026-04-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":94631,"price":14.5,"value":1372149.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities were disposed of in connection with consummation of the acquisition of the Issuer by BioMarin Pharmaceutical Inc. (the \"Merger\"), which included 31,000 shares of Common Stock and 63,631 restricted stock units (which vested in full in connection with consummation of the Merger)."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-182284","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000119312526182284/ownership.xml","form_type":"4"}},{"id":1103157,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-24T22:35:41.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":18884,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 20, 2024 grant date subject to continued service on the Company's Board of Directors through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 20, 2024 grant date subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":18884,"derivative":{"underlying":"Common Stock","underlying_shares":18884},"source":{"system":"sec-edgar","filing":"0001104659-25-062191","document":"tm2518838-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465925062191/tm2518838-1_4seq1.xml","form_type":"4"}},{"id":1103156,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-24T22:35:41.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":28326,"price":6.42,"value":181852.92,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the shares subject to this option grant under the Amended and Restated 2015 Stock Incentive Plan, as amended, will vest on the first anniversary of the June 20, 2024 grant date subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":28326,"derivative":{"exercise_price":6.42,"expiration_date":"2035-06-20","underlying":"Common Stock","underlying_shares":28326},"source":{"system":"sec-edgar","filing":"0001104659-25-062191","document":"tm2518838-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465925062191/tm2518838-1_4seq1.xml","form_type":"4"}},{"id":1110365,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2025-06-16T20:10:45.000Z","date":"2025-06-12","kind":"exercise","planned":false,"acquired":false,"shares":10420,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2025-06-12","expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":10420},"source":{"system":"sec-edgar","filing":"0001593968-25-000784","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396825000784/primary_01.xml","form_type":"4"}},{"id":1110364,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-16T20:10:45.000Z","date":"2025-06-12","kind":"exercise","planned":false,"acquired":true,"shares":10420,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25588,"source":{"system":"sec-edgar","filing":"0001593968-25-000784","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396825000784/primary_01.xml","form_type":"4"}},{"id":1120059,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2025-06-06T20:59:48.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":74872,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One hundred percent of the shares subject to this option will vest and become exercisable on the one year anniversary of the date of grant."}],"balance_after":74872,"derivative":{"exercise_price":5.96,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":74872},"source":{"system":"sec-edgar","filing":"0000950170-25-083225","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000095017025083225/ownership.xml","form_type":"4"}},{"id":1120058,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-06T20:59:48.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":20414,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted in the form of Restricted Stock Units (\"RSUs\"), these RSUs will vest in full on the one year anniversary of the grant date and shall be payable in common stock. One (1) RSU is the equivalent of one (1) share of Amicus common stock."}],"balance_after":91550,"source":{"system":"sec-edgar","filing":"0000950170-25-083225","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000095017025083225/ownership.xml","form_type":"4"}},{"id":1282652,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-06T00:04:50.000Z","date":"2024-12-31","kind":"grant","planned":false,"acquired":true,"shares":1178,"price":8.61,"value":10142.58,"ownership":{"direct":true},"balance_after":15168,"source":{"system":"sec-edgar","filing":"0001104659-25-009785","document":"tm255659-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465925009785/tm255659-1_4seq1.xml","form_type":"4"}},{"id":1282651,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-06T00:04:50.000Z","date":"2024-09-30","kind":"grant","planned":false,"acquired":true,"shares":778,"price":12.77,"value":9935.06,"ownership":{"direct":true},"balance_after":13990,"source":{"system":"sec-edgar","filing":"0001104659-25-009785","document":"tm255659-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465925009785/tm255659-1_4seq1.xml","form_type":"4"}},{"id":1282650,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-06T00:04:50.000Z","date":"2024-06-30","kind":"grant","planned":false,"acquired":true,"shares":713,"price":13.93,"value":9932.09,"ownership":{"direct":true},"balance_after":13212,"source":{"system":"sec-edgar","filing":"0001104659-25-009785","document":"tm255659-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465925009785/tm255659-1_4seq1.xml","form_type":"4"}},{"id":1282649,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-06T00:04:50.000Z","date":"2024-03-31","kind":"grant","planned":false,"acquired":true,"shares":2029,"price":4.9,"value":9942.1,"ownership":{"direct":true},"balance_after":5829,"source":{"system":"sec-edgar","filing":"0001104659-25-009785","document":"tm255659-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465925009785/tm255659-1_4seq1.xml","form_type":"4"}},{"id":1479737,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2024-06-14T20:14:45.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":10420,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10420,"derivative":{"exercise_price":0,"exercise_date":"2025-06-12","expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":10420},"source":{"system":"sec-edgar","filing":"0001593968-24-000865","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396824000865/primary_01.xml","form_type":"4"}},{"id":1479736,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-14T20:14:45.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":15630,"price":15.86,"value":247891.8,"ownership":{"direct":true},"balance_after":15630,"derivative":{"exercise_price":15.86,"exercise_date":"2025-06-12","expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":15630},"source":{"system":"sec-edgar","filing":"0001593968-24-000865","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396824000865/primary_01.xml","form_type":"4"}},{"id":1479735,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2024-06-14T20:14:45.000Z","date":"2024-06-12","kind":"exercise","planned":false,"acquired":false,"shares":6670,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2024-06-12","expiration_date":"2033-06-12","underlying":"Common Stock","underlying_shares":6670},"source":{"system":"sec-edgar","filing":"0001593968-24-000865","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396824000865/primary_01.xml","form_type":"4"}},{"id":1479734,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-14T20:14:45.000Z","date":"2024-06-12","kind":"exercise","planned":false,"acquired":true,"shares":6670,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10470,"source":{"system":"sec-edgar","filing":"0001593968-24-000865","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396824000865/primary_01.xml","form_type":"4"}},{"id":1487245,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2024-06-07T23:41:47.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":42467,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One hundred percent of the shares subject to this option will vest and become exercisable on the one year anniversary of the date of grant."}],"balance_after":42467,"derivative":{"exercise_price":10.27,"expiration_date":"2034-06-06","underlying":"Common Stock","underlying_shares":42467},"source":{"system":"sec-edgar","filing":"0000950170-24-071002","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000095017024071002/ownership.xml","form_type":"4"}},{"id":1487244,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-07T23:41:47.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":11847,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted in the form of Restricted Stock Units (\"RSUs\"), these RSUs will vest in full on the one year anniversary of the grant date and shall be payable in common stock. One (1) RSU is the equivalent of one (1) share of Amicus common stock."}],"balance_after":71136,"source":{"system":"sec-edgar","filing":"0000950170-24-071002","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000095017024071002/ownership.xml","form_type":"4"}},{"id":1592211,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2024-03-06T22:21:12.000Z","date":"2024-03-05","kind":"exercise","planned":true,"acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All of the options were fully vested and exercisable as of the transaction date."}],"balance_after":0,"derivative":{"exercise_price":2.8,"expiration_date":"2024-06-12","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0000950170-24-027334","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000095017024027334/ownership.xml","form_type":"4"}},{"id":1592210,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2024-03-06T22:21:12.000Z","date":"2024-03-04","kind":"exercise","planned":true,"acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All of the options were fully vested and exercisable as of the transaction date."}],"balance_after":7500,"derivative":{"exercise_price":2.8,"expiration_date":"2024-06-12","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0000950170-24-027334","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000095017024027334/ownership.xml","form_type":"4"}},{"id":1592209,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-06T22:21:12.000Z","date":"2024-03-05","kind":"sale","planned":true,"acquired":false,"shares":7500,"price":13.4,"value":100500.0,"ownership":{"direct":true},"balance_after":59289,"source":{"system":"sec-edgar","filing":"0000950170-24-027334","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000095017024027334/ownership.xml","form_type":"4"}},{"id":1592208,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-06T22:21:12.000Z","date":"2024-03-05","kind":"exercise","planned":true,"acquired":true,"shares":7500,"price":2.8,"value":21000.0,"ownership":{"direct":true},"balance_after":66789,"source":{"system":"sec-edgar","filing":"0000950170-24-027334","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000095017024027334/ownership.xml","form_type":"4"}},{"id":1592207,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-06T22:21:12.000Z","date":"2024-03-04","kind":"sale","planned":true,"acquired":false,"shares":7500,"price":13.29,"value":99675.0,"ownership":{"direct":true},"balance_after":59289,"source":{"system":"sec-edgar","filing":"0000950170-24-027334","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000095017024027334/ownership.xml","form_type":"4"}},{"id":1592206,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-06T22:21:12.000Z","date":"2024-03-04","kind":"exercise","planned":true,"acquired":true,"shares":7500,"price":2.8,"value":21000.0,"ownership":{"direct":true},"balance_after":66789,"source":{"system":"sec-edgar","filing":"0000950170-24-027334","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000095017024027334/ownership.xml","form_type":"4"}},{"id":1857758,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-13T20:47:02.000Z","date":"2023-06-12","kind":"grant","planned":false,"acquired":true,"shares":6670,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One hundred percent (100%) of the RSUs subject to this grant under the Plan will vest one (1) year from the Grant Date subject to continued service on the Company's Board of Directors through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"One hundred percent (100%) of the RSUs subject to this grant under the Plan will vest one (1) year from the Grant Date subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":6670,"derivative":{"underlying":"Common Stock","underlying_shares":6670},"source":{"system":"sec-edgar","filing":"0001209191-23-036754","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919123036754/doc4.xml","form_type":"4"}},{"id":1857757,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-13T20:47:02.000Z","date":"2023-06-12","kind":"grant","planned":false,"acquired":true,"shares":7710,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the shares subject to this option grant under the Plan will vest one (1) year from the June 12, 2023 grant date (the \"Grant Date\") subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":7710,"derivative":{"exercise_price":7.78,"exercise_date":"2024-06-12","expiration_date":"2033-06-12","underlying":"Common Stock","underlying_shares":7710},"source":{"system":"sec-edgar","filing":"0001209191-23-036754","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919123036754/doc4.xml","form_type":"4"}},{"id":1857756,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-13T20:47:02.000Z","date":"2023-06-10","kind":"exercise","planned":false,"acquired":false,"shares":3100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended (the \"Plan\"), vested on the first anniversary of the June 10, 2022 grant date subject to continued service on the Company's Board of Directors through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended (the \"Plan\"), vested on the first anniversary of the June 10, 2022 grant date subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3100},"source":{"system":"sec-edgar","filing":"0001209191-23-036754","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919123036754/doc4.xml","form_type":"4"}},{"id":1857755,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-13T20:47:02.000Z","date":"2023-06-10","kind":"exercise","planned":false,"acquired":true,"shares":3100,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."}],"balance_after":3800,"source":{"system":"sec-edgar","filing":"0001209191-23-036754","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919123036754/doc4.xml","form_type":"4"}},{"id":1859207,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2023-06-12T21:41:11.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":30474,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One hundred percent of the shares subject to this option will vest and become exercisable on the one year anniversary of the date of grant."}],"balance_after":30474,"derivative":{"exercise_price":12.62,"expiration_date":"2033-06-08","underlying":"Common Stock","underlying_shares":30474},"source":{"system":"sec-edgar","filing":"0001209191-23-036434","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919123036434/doc4.xml","form_type":"4"}},{"id":1859206,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-12T21:41:11.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":8584,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted in the form of Restricted Stock Units (\"RSUs\"), these RSUs will vest in full on the one year anniversary of the grant date and shall be payable in common stock. One (1) RSU is the equivalent of one (1) share of Amicus common stock."}],"balance_after":59289,"source":{"system":"sec-edgar","filing":"0001209191-23-036434","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919123036434/doc4.xml","form_type":"4"}},{"id":349492,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-03T20:59:42.000Z","date":"2023-05-01","kind":"grant","planned":false,"acquired":true,"shares":3481,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested."}],"balance_after":3481,"derivative":{"exercise_price":342.73,"expiration_date":"2033-04-30","underlying":"Common Stock","underlying_shares":3481},"source":{"system":"sec-edgar","filing":"0001209191-23-027038","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123027038/doc4.xml","form_type":"4"}},{"id":2053929,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2023-01-17T23:03:17.000Z","date":"2023-01-13","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All of these options were fully vested and exercisable as of the transaction date."}],"balance_after":0,"derivative":{"exercise_price":3.32,"expiration_date":"2023-06-13","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-23-003573","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919123003573/doc4.xml","form_type":"4"}},{"id":2053928,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-17T23:03:17.000Z","date":"2023-01-13","kind":"sale","acquired":false,"shares":15000,"price":13.0258,"value":195387.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $13.00 to $13.10 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":50705,"source":{"system":"sec-edgar","filing":"0001209191-23-003573","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919123003573/doc4.xml","form_type":"4"}},{"id":2053927,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-17T23:03:17.000Z","date":"2023-01-13","kind":"exercise","acquired":true,"shares":15000,"price":3.32,"value":49800.0,"ownership":{"direct":true},"balance_after":65705,"source":{"system":"sec-edgar","filing":"0001209191-23-003573","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919123003573/doc4.xml","form_type":"4"}},{"id":2226052,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-22T00:47:53.000Z","date":"2022-06-17","kind":"exercise","acquired":false,"shares":700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 17, 2021 grant date subject to continued service on the Company's Board of Directors through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 17, 2021 grant date subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":700},"source":{"system":"sec-edgar","filing":"0001209191-22-038594","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919122038594/doc4.xml","form_type":"4"}},{"id":2226051,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-22T00:47:53.000Z","date":"2022-06-17","kind":"exercise","acquired":true,"shares":700,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."}],"balance_after":700,"source":{"system":"sec-edgar","filing":"0001209191-22-038594","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919122038594/doc4.xml","form_type":"4"}},{"id":2233204,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-14T21:09:10.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":3100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Company common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the RSUs subject to this grant under the Plan will vest one (1) year from the Grant Date subject to continued service on the Company's Board of Directors through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One hundred percent (100%) of the RSUs subject to this grant under the Plan will vest one (1) year from the Grant Date subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":3100,"derivative":{"underlying":"Common Stock","underlying_shares":3100},"source":{"system":"sec-edgar","filing":"0001209191-22-036755","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919122036755/doc4.xml","form_type":"4"}},{"id":2233203,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-14T21:09:10.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":4600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One hundred percent (100%) of the shares subject to this option grant under the Novavax, Inc. (the \"Company\") Amended and Restated 2015 Stock Incentive Plan, as amended (the \"Plan\") will vest one (1) year from the June 10, 2022 grant date (the \"Grant Date\") subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":4600,"derivative":{"exercise_price":40.62,"exercise_date":"2023-06-10","expiration_date":"2032-06-10","underlying":"Common Stock","underlying_shares":4600},"source":{"system":"sec-edgar","filing":"0001209191-22-036755","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919122036755/doc4.xml","form_type":"4"}},{"id":2236441,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2022-06-10T20:09:32.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":45423,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One hundred percent of the shares subject to this option will vest and become exercisable on the one year anniversary of the date of grant."}],"balance_after":45423,"derivative":{"exercise_price":8.55,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":45423},"source":{"system":"sec-edgar","filing":"0001209191-22-035836","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919122035836/doc4.xml","form_type":"4"}},{"id":2236440,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-10T20:09:32.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":12671,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted in the form of Restricted Stock Units (\"RSUs\"), these RSUs will vest in full on the one year anniversary of the grant date and shall be payable in common stock. One (1) RSU is the equivalent of one (1) share of Amicus common stock."}],"balance_after":50705,"source":{"system":"sec-edgar","filing":"0001209191-22-035836","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919122035836/doc4.xml","form_type":"4"}},{"id":2282552,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2022-05-04T23:37:08.000Z","date":"2022-05-02","kind":"disposition_to_issuer","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All of these options were fully vested and exercisable as of the transaction date."}],"balance_after":0,"derivative":{"exercise_price":4.79,"expiration_date":"2022-06-13","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-22-027245","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919122027245/doc4.xml","form_type":"4"}},{"id":2282551,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-04T23:37:08.000Z","date":"2022-05-02","kind":"sale","acquired":false,"shares":15000,"price":6.9931,"value":104896.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $6.83 to $7.16 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":38034,"source":{"system":"sec-edgar","filing":"0001209191-22-027245","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919122027245/doc4.xml","form_type":"4"}},{"id":2282550,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-04T23:37:08.000Z","date":"2022-05-02","kind":"exercise","acquired":true,"shares":15000,"price":4.79,"value":71850.0,"ownership":{"direct":true},"balance_after":53034,"source":{"system":"sec-edgar","filing":"0001209191-22-027245","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919122027245/doc4.xml","form_type":"4"}},{"id":361993,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-03T20:47:33.000Z","date":"2022-05-01","kind":"grant","acquired":true,"shares":4462,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4462,"derivative":{"exercise_price":276.17,"exercise_date":"2022-05-01","expiration_date":"2032-04-30","underlying":"Common Stock","underlying_shares":4462},"source":{"system":"sec-edgar","filing":"0000899243-22-016336","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322016336/doc4.xml","form_type":"4"}},{"id":361992,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2022-05-03T20:47:33.000Z","date":"2022-05-01","kind":"grant","acquired":true,"shares":921,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McGlynn's service on the Issuer's board of directors, (ii) a change of control of the Issuer and (iii) Ms. McGlynn's disability or death."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the vesting of restricted stock units granted to Ms. McGlynn on May 1, 2021, Ms. McGlynn deferred the receipt of 921 shares of common stock and received instead 921 deferred stock units pursuant to the Issuer's deferred compensation plan. As a result, Ms. McGlynn is reporting the disposition of 921 shares of common stock in exchange for an equal number of deferred stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McGlynn's service on the Issuer's board of directors, (ii) a change of control of the Issuer and (iii) Ms. McGlynn's disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McGlynn's service on the Issuer's board of directors, (ii) a change of control of the Issuer and (iii) Ms. McGlynn's disability or death."}],"balance_after":5609,"derivative":{"underlying":"Common Stock","underlying_shares":921},"source":{"system":"sec-edgar","filing":"0000899243-22-016336","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322016336/doc4.xml","form_type":"4"}},{"id":361991,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-03T20:47:33.000Z","date":"2022-05-01","kind":"disposition_to_issuer","acquired":false,"shares":921,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the vesting of restricted stock units granted to Ms. McGlynn on May 1, 2021, Ms. McGlynn deferred the receipt of 921 shares of common stock and received instead 921 deferred stock units pursuant to the Issuer's deferred compensation plan. As a result, Ms. McGlynn is reporting the disposition of 921 shares of common stock in exchange for an equal number of deferred stock units."}],"balance_after":178,"source":{"system":"sec-edgar","filing":"0000899243-22-016336","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322016336/doc4.xml","form_type":"4"}},{"id":362775,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-12T20:05:43.000Z","date":"2022-04-08","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully vested."}],"balance_after":5000,"derivative":{"exercise_price":127.54,"expiration_date":"2025-05-31","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000899243-22-014548","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014548/doc4.xml","form_type":"4"}},{"id":362774,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-12T20:05:43.000Z","date":"2022-04-08","kind":"sale","acquired":false,"shares":100,"price":281.49,"value":28149.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. McGlynn's company approved trading plan under Rule 10b5-1."}],"balance_after":1099,"source":{"system":"sec-edgar","filing":"0000899243-22-014548","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014548/doc4.xml","form_type":"4"}},{"id":362773,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-12T20:05:43.000Z","date":"2022-04-08","kind":"sale","acquired":false,"shares":4900,"price":280.19,"value":1372931.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. McGlynn's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Ms. McGlynn undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Open market sales reported on this line occurred at a weighted average price of $280.19 (range $280.00 to $280.95)."}],"balance_after":1199,"source":{"system":"sec-edgar","filing":"0000899243-22-014548","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014548/doc4.xml","form_type":"4"}},{"id":362772,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-12T20:05:43.000Z","date":"2022-04-08","kind":"exercise","acquired":true,"shares":5000,"price":127.54,"value":637700.0,"ownership":{"direct":true},"balance_after":6099,"source":{"system":"sec-edgar","filing":"0000899243-22-014548","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014548/doc4.xml","form_type":"4"}},{"id":363176,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (right to buy)","published_at":"2022-04-04T20:05:30.000Z","date":"2022-03-31","kind":"exercise","acquired":false,"shares":5000,"price":127.54,"value":637700.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Fully vested"}],"balance_after":10000,"derivative":{"exercise_price":127.54,"expiration_date":"2025-05-31","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000899243-22-013305","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322013305/doc4.xml","form_type":"4"}},{"id":363175,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-04T20:05:30.000Z","date":"2022-03-31","kind":"sale","acquired":false,"shares":1011,"price":262.97,"value":265862.67,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. McGlynn's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Ms. McGlynn undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $262.97 (range $262.80 to $263.34)."}],"balance_after":1099,"source":{"system":"sec-edgar","filing":"0000899243-22-013305","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322013305/doc4.xml","form_type":"4"}},{"id":363174,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-04T20:05:30.000Z","date":"2022-03-31","kind":"sale","acquired":false,"shares":2970,"price":262.37,"value":779238.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. McGlynn's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Ms. McGlynn undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $262.37 (range $261.79 to $262.78)."}],"balance_after":2110,"source":{"system":"sec-edgar","filing":"0000899243-22-013305","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322013305/doc4.xml","form_type":"4"}},{"id":363173,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-04T20:05:30.000Z","date":"2022-03-31","kind":"sale","acquired":false,"shares":1019,"price":261.28,"value":266244.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. McGlynn's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $261.28 (range $260.78 to $261.73)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Ms. McGlynn undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":5080,"source":{"system":"sec-edgar","filing":"0000899243-22-013305","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322013305/doc4.xml","form_type":"4"}},{"id":363172,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-04T20:05:30.000Z","date":"2022-03-31","kind":"exercise","acquired":true,"shares":5000,"price":127.54,"value":637700.0,"ownership":{"direct":true},"balance_after":6099,"source":{"system":"sec-edgar","filing":"0000899243-22-013305","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322013305/doc4.xml","form_type":"4"}},{"id":366889,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-01T21:09:14.000Z","date":"2022-01-28","kind":"exercise","acquired":false,"shares":5000,"price":127.54,"value":637700.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Fully vested."}],"balance_after":15000,"derivative":{"exercise_price":127.54,"expiration_date":"2025-05-31","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-22-005895","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919122005895/doc4.xml","form_type":"4"}},{"id":366888,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-01T21:09:14.000Z","date":"2022-01-28","kind":"sale","acquired":false,"shares":212,"price":243.24,"value":51566.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. McGlynn's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Ms. McGlynn undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Open market sales reported on this line occurred at a weighted average price of $243.24 (range $243.21 to $243.27)."}],"balance_after":1099,"source":{"system":"sec-edgar","filing":"0001209191-22-005895","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919122005895/doc4.xml","form_type":"4"}},{"id":366887,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-01T21:09:14.000Z","date":"2022-01-28","kind":"sale","acquired":false,"shares":2087,"price":242.78,"value":506681.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. McGlynn's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Ms. McGlynn undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $242.78 (range $242.18 to $243.14)."}],"balance_after":1311,"source":{"system":"sec-edgar","filing":"0001209191-22-005895","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919122005895/doc4.xml","form_type":"4"}},{"id":366886,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-01T21:09:14.000Z","date":"2022-01-28","kind":"sale","acquired":false,"shares":800,"price":241.83,"value":193464.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. McGlynn's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Ms. McGlynn undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $241.83 (range $241.16 to $242.15)."}],"balance_after":3398,"source":{"system":"sec-edgar","filing":"0001209191-22-005895","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919122005895/doc4.xml","form_type":"4"}},{"id":366885,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-01T21:09:14.000Z","date":"2022-01-28","kind":"sale","acquired":false,"shares":1901,"price":240.53,"value":457247.53,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. McGlynn's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $240.53 (range $240.01 to $240.92)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Ms. McGlynn undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":4198,"source":{"system":"sec-edgar","filing":"0001209191-22-005895","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919122005895/doc4.xml","form_type":"4"}},{"id":366884,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-01T21:09:14.000Z","date":"2022-01-28","kind":"exercise","acquired":true,"shares":5000,"price":127.54,"value":637700.0,"ownership":{"direct":true},"balance_after":6099,"source":{"system":"sec-edgar","filing":"0001209191-22-005895","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919122005895/doc4.xml","form_type":"4"}},{"id":2659498,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-06-22T21:19:15.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Company common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the RSUs subject to this grant under the Plan will vest one (1) year from the Grant Date subject to continued service on the Company's Board of Directors through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One hundred percent (100%) of the RSUs subject to this grant under the Plan will vest one (1) year from the Grant Date subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":700,"derivative":{"underlying":"Common Stock","underlying_shares":700},"source":{"system":"sec-edgar","filing":"0001209191-21-042455","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121042455/doc4.xml","form_type":"4"}},{"id":2659497,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-22T21:19:15.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":1300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One hundred percent (100%) of the shares subject to this option grant under the Novavax, Inc. (the \"Company\") Amended and Restated 2015 Stock Incentive Plan, as amended (the \"Plan\") will vest one (1) year from the June 17, 2021 grant date (the \"Grant Date\") subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":1300,"derivative":{"exercise_price":179.89,"exercise_date":"2022-06-17","expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":1300},"source":{"system":"sec-edgar","filing":"0001209191-21-042455","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121042455/doc4.xml","form_type":"4"}},{"id":2670500,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2021-06-14T23:12:03.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":36111,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One hundred percent of the shares subject to this option will vest and become exercisable on the one year anniversary of the date of grant."}],"balance_after":36111,"derivative":{"exercise_price":10.71,"expiration_date":"2031-06-10","underlying":"Common Stock","underlying_shares":36111},"source":{"system":"sec-edgar","filing":"0001209191-21-040392","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919121040392/doc4.xml","form_type":"4"}},{"id":2670499,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-14T23:12:03.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":10115,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted in the form of Restricted Stock Units (\"RSUs\"), these RSUs will vest in full on the one year anniversary of the grant date and shall be payable in common stock. One (1) RSU is the equivalent of one (1) share of Amicus common stock."}],"balance_after":38034,"source":{"system":"sec-edgar","filing":"0001209191-21-040392","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919121040392/doc4.xml","form_type":"4"}},{"id":374721,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2021-06-03T20:09:30.000Z","date":"2021-06-01","kind":"grant","acquired":true,"shares":699,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McGlynn's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McGlynn's disability or death."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the vesting of restricted stock units granted to Ms. McGlynn on June 1, 2020, Ms. McGlynn deferred the receipt of 699 shares of common stock and received instead 699 deferred stock units pursuant to the Company's deferred compensation plan. As a result, Ms. McGlynn is reporting the disposition of 699 shares of common stock in exchange for an equal number of deferred stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McGlynn's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McGlynn's disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McGlynn's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McGlynn's disability or death."}],"balance_after":4688,"derivative":{"underlying":"Common Stock","underlying_shares":699},"source":{"system":"sec-edgar","filing":"0001209191-21-037619","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121037619/doc4.xml","form_type":"4"}},{"id":374720,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-03T20:09:30.000Z","date":"2021-06-01","kind":"disposition_to_issuer","acquired":false,"shares":699,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the vesting of restricted stock units granted to Ms. McGlynn on June 1, 2020, Ms. McGlynn deferred the receipt of 699 shares of common stock and received instead 699 deferred stock units pursuant to the Company's deferred compensation plan. As a result, Ms. McGlynn is reporting the disposition of 699 shares of common stock in exchange for an equal number of deferred stock units."}],"balance_after":1099,"source":{"system":"sec-edgar","filing":"0001209191-21-037619","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121037619/doc4.xml","form_type":"4"}},{"id":2727694,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2021-05-05T22:01:52.000Z","date":"2021-05-03","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All of these options were fully vested and exercisable as of the transaction date."}],"balance_after":0,"derivative":{"exercise_price":7.51,"expiration_date":"2021-05-24","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-030441","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919121030441/doc4.xml","form_type":"4"}},{"id":2727693,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-05T22:01:52.000Z","date":"2021-05-03","kind":"sale","acquired":false,"shares":10000,"price":10.2704,"value":102704.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $10.24 to $10.39 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":27919,"source":{"system":"sec-edgar","filing":"0001209191-21-030441","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919121030441/doc4.xml","form_type":"4"}},{"id":2727692,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-05T22:01:52.000Z","date":"2021-05-03","kind":"exercise","acquired":true,"shares":10000,"price":7.51,"value":75100.0,"ownership":{"direct":true},"balance_after":37919,"source":{"system":"sec-edgar","filing":"0001209191-21-030441","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919121030441/doc4.xml","form_type":"4"}},{"id":376076,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-04T20:17:07.000Z","date":"2021-05-01","kind":"grant","acquired":true,"shares":3034,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested."}],"balance_after":3034,"derivative":{"exercise_price":217.2,"expiration_date":"2031-04-30","underlying":"Common Stock","underlying_shares":3034},"source":{"system":"sec-edgar","filing":"0001209191-21-029861","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121029861/doc4.xml","form_type":"4"}},{"id":376075,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-04T20:17:07.000Z","date":"2021-05-01","kind":"grant","acquired":true,"shares":921,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit award that vests on the first anniversary of the grant date."}],"balance_after":1798,"source":{"system":"sec-edgar","filing":"0001209191-21-029861","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121029861/doc4.xml","form_type":"4"}},{"id":2952380,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2020-12-09T23:01:35.000Z","date":"2020-12-07","kind":"grant","acquired":true,"shares":7700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One hundred percent (100%) of the shares subject to this option grant under the Novavax, Inc. (the \"Company\") Amended and Restated 2015 Stock Incentive Plan, as amended, will vest one (1) year from the December 7, 2020 grant date subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":7700,"derivative":{"exercise_price":123.12,"exercise_date":"2021-12-07","expiration_date":"2030-12-07","underlying":"Common Stock","underlying_shares":7700},"source":{"system":"sec-edgar","filing":"0001209191-20-062595","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919120062595/doc4.xml","form_type":"4"}},{"id":3019579,"issuer":{"id":2983,"kind":"organization","name":"Air Products & Chemicals, Inc.","symbol":"APD"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true}}],"security":"Phantom Stock","published_at":"2020-10-01T17:50:33.000Z","date":"2020-09-30","kind":"grant","acquired":true,"shares":194.3437,"price":293.86,"value":57109.839682,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Phantom deferred stock units (Units) acquired under the Air Products Stock Account of the issuer's Deferred Compensation Program for Directors, under the Company's Long-Term Incentive Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Not applicable to this security"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These Units are payable in the form of shares of common stock equal in number to the Units, at the time elected by the reporting person, which is generally after service on the Company's Board of Directors ends. Units may be paid in a lump sum or up to ten installments as elected by the reporting person in advance."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These Units are payable in the form of shares of common stock equal in number to the Units, at the time elected by the reporting person, which is generally after service on the Company's Board of Directors ends. Units may be paid in a lump sum or up to ten installments as elected by the reporting person in advance."}],"balance_after":42813.6292,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":194.3437},"source":{"system":"sec-edgar","filing":"0001225208-20-011934","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2969/000122520820011934/doc4.xml","form_type":"4"}},{"id":386871,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-26T20:14:23.000Z","date":"2020-08-25","kind":"gift","acquired":false,"shares":3707,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction represents a charitable donation effective August 25, 2020."}],"balance_after":877,"source":{"system":"sec-edgar","filing":"0001209191-20-048388","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120048388/doc4.xml","form_type":"4"}},{"id":3094797,"issuer":{"id":2983,"kind":"organization","name":"Air Products & Chemicals, Inc.","symbol":"APD"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true}}],"security":"Phantom Stock","published_at":"2020-07-02T17:24:43.000Z","date":"2020-06-30","kind":"grant","acquired":true,"shares":238.0073,"price":238.61,"value":56790.921853,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Phantom deferred stock units (Units) acquired under the Air Products Stock Account of the issuer's Deferred Compensation Program for Directors, under the Company's Long-Term Incentive Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Not applicable to this security"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These Units are payable in the form of shares of common stock equal in number to the Units, at the time elected by the reporting person, which is generally after service on the Company's Board of Directors ends. Units may be paid in a lump sum or up to ten installments as elected by the reporting person in advance."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These Units are payable in the form of shares of common stock equal in number to the Units, at the time elected by the reporting person, which is generally after service on the Company's Board of Directors ends. Units may be paid in a lump sum or up to ten installments as elected by the reporting person in advance."}],"balance_after":42619.2855,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":238.0073},"source":{"system":"sec-edgar","filing":"0001225208-20-009436","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2969/000122520820009436/doc4.xml","form_type":"4"}},{"id":3118975,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2020-06-08T20:54:46.000Z","date":"2020-06-04","kind":"grant","acquired":true,"shares":18574,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One hundred percent of the shares subject to this option will vest and become exercisable on the one year anniversary of the date of grant."}],"balance_after":18574,"derivative":{"exercise_price":12.81,"expiration_date":"2030-06-04","underlying":"Common Stock","underlying_shares":18574},"source":{"system":"sec-edgar","filing":"0001209191-20-035003","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919120035003/doc4.xml","form_type":"4"}},{"id":3118974,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-08T20:54:46.000Z","date":"2020-06-04","kind":"grant","acquired":true,"shares":5855,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted in the form of Restricted Stock Units (\"RSUs\"), these RSUs will vest in full on the one year anniversary of the grant date and shall be payable in common stock. One (1) RSU is the equivalent of one (1) share of Amicus common stock."}],"balance_after":27919,"source":{"system":"sec-edgar","filing":"0001209191-20-035003","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919120035003/doc4.xml","form_type":"4"}},{"id":389772,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-03T20:35:10.000Z","date":"2020-06-01","kind":"grant","acquired":true,"shares":2264,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested."}],"balance_after":2264,"derivative":{"exercise_price":286.27,"expiration_date":"2030-05-31","underlying":"Common Stock","underlying_shares":2264},"source":{"system":"sec-edgar","filing":"0001209191-20-034048","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120034048/doc4.xml","form_type":"4"}},{"id":389771,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-03T20:35:10.000Z","date":"2020-06-01","kind":"grant","acquired":true,"shares":699,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date."}],"balance_after":4584,"source":{"system":"sec-edgar","filing":"0001209191-20-034048","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120034048/doc4.xml","form_type":"4"}},{"id":3173143,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2020-04-20T20:57:42.000Z","date":"2020-04-17","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All of these options were fully vested and exercisable as of April 17, 2020."}],"balance_after":0,"derivative":{"exercise_price":2.81,"expiration_date":"2020-06-15","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-20-025089","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919120025089/doc4.xml","form_type":"4"}},{"id":3173142,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-20T20:57:42.000Z","date":"2020-04-17","kind":"sale","acquired":false,"shares":10000,"price":11,"value":110000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":22064,"source":{"system":"sec-edgar","filing":"0001209191-20-025089","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919120025089/doc4.xml","form_type":"4"}},{"id":3173141,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-20T20:57:42.000Z","date":"2020-04-17","kind":"exercise","acquired":true,"shares":10000,"price":2.81,"value":28100.0,"ownership":{"direct":true},"balance_after":32064,"source":{"system":"sec-edgar","filing":"0001209191-20-025089","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919120025089/doc4.xml","form_type":"4"}},{"id":3188586,"issuer":{"id":2983,"kind":"organization","name":"Air Products & Chemicals, Inc.","symbol":"APD"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true}}],"security":"Phantom Stock","published_at":"2020-04-02T15:13:35.000Z","date":"2020-03-31","kind":"grant","acquired":true,"shares":236.7099,"price":206.53,"value":48887.695647,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Phantom deferred stock units (Units) acquired under the Air Products Stock Account of the issuer's Deferred Compensation Program for Directors, under the Company's Long-Term Incentive Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Not applicable to this security"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These Units are payable in the form of shares of common stock equal in number to the Units, at the time elected by the reporting person, which is generally after service on the Company's Board of Directors ends. Units may be paid in a lump sum or up to ten installments as elected by the reporting person in advance."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These Units are payable in the form of shares of common stock equal in number to the Units, at the time elected by the reporting person, which is generally after service on the Company's Board of Directors ends. Units may be paid in a lump sum or up to ten installments as elected by the reporting person in advance."}],"balance_after":42381.2782,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":236.7099},"source":{"system":"sec-edgar","filing":"0001225208-20-005835","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2969/000122520820005835/doc4.xml","form_type":"4"}},{"id":3303715,"issuer":{"id":2983,"kind":"organization","name":"Air Products & Chemicals, Inc.","symbol":"APD"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true}}],"security":"Phantom Stock","published_at":"2020-01-24T17:37:43.000Z","date":"2020-01-23","kind":"grant","acquired":true,"shares":630.1462,"price":238.04,"value":150000.001448,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Phantom deferred stock units (Units) acquired under the Air Products Stock Account of the issuer's Deferred Compensation Program for Directors, under the Company's Long-Term Incentive Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Not applicable to this security"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These Units are payable in the form of shares of common stock equal in number to the Units, at the time elected by the reporting person, which is generally after service on the Company's Board of Directors ends. Units may be paid in a lump sum or up to ten installments as elected by the reporting person in advance."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These Units are payable in the form of shares of common stock equal in number to the Units, at the time elected by the reporting person, which is generally after service on the Company's Board of Directors ends. Units may be paid in a lump sum or up to ten installments as elected by the reporting person in advance."}],"balance_after":42144.5683,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":630.1462},"source":{"system":"sec-edgar","filing":"0001225208-20-001102","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2969/000122520820001102/doc4.xml","form_type":"4"}},{"id":3313713,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2020-01-10T22:34:14.000Z","date":"2020-01-09","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All of these options were fully vested and exercisable as of January 9, 2020."}],"balance_after":0,"derivative":{"exercise_price":3.32,"expiration_date":"2020-03-16","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-20-003096","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919120003096/doc4.xml","form_type":"4"}},{"id":3313712,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-10T22:34:14.000Z","date":"2020-01-09","kind":"sale","acquired":false,"shares":20000,"price":10,"value":200000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":22064,"source":{"system":"sec-edgar","filing":"0001209191-20-003096","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919120003096/doc4.xml","form_type":"4"}},{"id":3313711,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":15358,"kind":"person","name":"MCGLYNN MARGARET G","position":1,"cik":"0001215126","reported_name":"MCGLYNN MARGARET G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-10T22:34:14.000Z","date":"2020-01-09","kind":"exercise","acquired":true,"shares":20000,"price":3.32,"value":66400.0,"ownership":{"direct":true},"balance_after":42064,"source":{"system":"sec-edgar","filing":"0001209191-20-003096","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919120003096/doc4.xml","form_type":"4"}}],"next_cursor":"2020-01-10T22:34:14.000000Z,3313711"}